Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Age-specific effects of hormone therapy use on overall mortality and ischemic heart disease mortality among women in the California Teachers Study.

Stram DO, Liu Y, Henderson KD, Sullivan-Halley J, Luo J, Saxena T, Reynolds P, Chang ET, Neuhausen SL, Horn-Ross PL, Bernstein L, Ursin G.

Menopause. 2011 Mar;18(3):253-61. doi: 10.1097/gme.0b013e3181f0839a.

2.

Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative.

Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.

Obstet Gynecol. 2014 Nov;124(5):947-53. doi: 10.1097/AOG.0000000000000461.

PMID:
25437723
3.

Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.

Grodstein F, Manson JE, Stampfer MJ.

J Womens Health (Larchmt). 2006 Jan-Feb;15(1):35-44.

PMID:
16417416
4.

Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women's Health Initiative Hormone Therapy clinical trials.

Canonico M, Plu-Bureau G, O'Sullivan MJ, Stefanick ML, Cochrane B, Scarabin PY, Manson JE.

Menopause. 2014 Mar;21(3):214-20. doi: 10.1097/GME.0b013e31829752e0.

5.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
6.

Physical activity and colon cancer risk among women in the California Teachers Study.

Mai PL, Sullivan-Halley J, Ursin G, Stram DO, Deapen D, Villaluna D, Horn-Ross PL, Clarke CA, Reynolds P, Ross RK, West DW, Anton-Culver H, Ziogas A, Bernstein L.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):517-25.

7.

Postmenopausal hormone therapy and migraine headache.

Misakian AL, Langer RD, Bensenor IM, Cook NR, Manson JE, Buring JE, Rexrode KM.

J Womens Health (Larchmt). 2003 Dec;12(10):1027-36.

PMID:
14709191
8.

Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study.

Jacobsen BK, Knutsen SF, Fraser GE.

J Clin Epidemiol. 1999 Apr;52(4):303-7.

PMID:
10235170
9.

Vasomotor symptoms and mortality: the Rancho Bernardo Study.

Svartberg J, von Mühlen D, Kritz-Silverstein D, Barrett-Connor E.

Menopause. 2009 Sep-Oct;16(5):888-91. doi: 10.1097/gme.0b013e3181a4866b.

PMID:
19421076
10.

The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.

Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F.

J Steroid Biochem Mol Biol. 2014 Jul;142:4-11. doi: 10.1016/j.jsbmb.2013.10.009. Epub 2013 Oct 27. Review.

PMID:
24172877
11.

Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes.

Bassuk SS, Manson JE.

Ann Epidemiol. 2015 Mar;25(3):193-200. doi: 10.1016/j.annepidem.2014.11.004. Epub 2014 Nov 13.

12.

Hormone therapy for preventing cardiovascular disease in post-menopausal women.

Boardman HM, Hartley L, Eisinga A, Main C, Roqué i Figuls M, Bonfill Cosp X, Gabriel Sanchez R, Knight B.

Cochrane Database Syst Rev. 2015 Mar 10;(3):CD002229. doi: 10.1002/14651858.CD002229.pub4. Review.

PMID:
25754617
13.

Bilateral oophorectomy is not associated with increased mortality: the California Teachers Study.

Duan L, Xu X, Koebnick C, Lacey JV Jr, Sullivan-Halley J, Templeman C, Marshall SF, Neuhausen SL, Ursin G, Bernstein L, Henderson KD.

Fertil Steril. 2012 Jan;97(1):111-7. doi: 10.1016/j.fertnstert.2011.10.004. Epub 2011 Nov 14.

14.
15.
16.

Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.

Wild RA, Wu C, Curb JD, Martin LW, Phillips L, Stefanick M, Trevisan M, Manson JE.

Menopause. 2013 Mar;20(3):254-60. doi: 10.1097/GME.0b013e31826f80e0.

17.

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML.

JAMA. 2007 Apr 4;297(13):1465-77. Erratum in: JAMA. 2008 Mar 26;299(12):1426.

PMID:
17405972
18.

The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y).

Vaughan L, Espeland MA, Snively B, Shumaker SA, Rapp SR, Shupe J, Robinson JG, Sarto GE, Resnick SM; Women's Health Initiative Memory Study of Younger Women (WHIMS-Y) Study Group..

Brain Res. 2013 Jun 13;1514:3-11. doi: 10.1016/j.brainres.2013.03.047. Epub 2013 Apr 8.

19.

Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality.

Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O.

Menopause. 2015 Sep;22(9):976-83. doi: 10.1097/GME.0000000000000450.

PMID:
25803671
20.

Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.

Banks E, Canfell K.

Am J Epidemiol. 2009 Jul 1;170(1):24-8. doi: 10.1093/aje/kwp113. Epub 2009 May 25.

PMID:
19468078

Supplemental Content

Support Center